Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 31 | 2024 | 1178 | 3.330 |
Why?
|
Aminophenols | 6 | 2023 | 78 | 0.760 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 8 | 2023 | 437 | 0.690 |
Why?
|
Benzodioxoles | 4 | 2023 | 69 | 0.480 |
Why?
|
Amiloride | 1 | 2012 | 121 | 0.430 |
Why?
|
Tobramycin | 1 | 2012 | 69 | 0.430 |
Why?
|
Burkholderia Infections | 1 | 2012 | 44 | 0.420 |
Why?
|
Quinolones | 4 | 2021 | 366 | 0.400 |
Why?
|
Patient Participation | 1 | 2020 | 1445 | 0.380 |
Why?
|
Chronic Disease | 3 | 2021 | 9144 | 0.310 |
Why?
|
Forced Expiratory Volume | 5 | 2023 | 1741 | 0.270 |
Why?
|
Hypoglycemia | 2 | 2024 | 859 | 0.260 |
Why?
|
Hyperglycemia | 2 | 2024 | 1368 | 0.240 |
Why?
|
Pandemics | 3 | 2021 | 8328 | 0.240 |
Why?
|
Chlorides | 3 | 2023 | 667 | 0.230 |
Why?
|
Bone Density | 4 | 2021 | 3469 | 0.230 |
Why?
|
Receptors, Serotonin | 4 | 1997 | 210 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
Radius | 2 | 2016 | 422 | 0.210 |
Why?
|
Azabicyclo Compounds | 1 | 2021 | 68 | 0.200 |
Why?
|
Epoxide Hydrolases | 1 | 2021 | 122 | 0.190 |
Why?
|
Men's Health | 1 | 2020 | 73 | 0.190 |
Why?
|
Pyrrolidines | 2 | 2021 | 342 | 0.180 |
Why?
|
Benzoates | 1 | 2021 | 217 | 0.180 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2024 | 436 | 0.180 |
Why?
|
Tibia | 2 | 2016 | 1075 | 0.170 |
Why?
|
Quipazine | 2 | 1997 | 6 | 0.160 |
Why?
|
Breathing Exercises | 1 | 2018 | 53 | 0.160 |
Why?
|
Inhalation | 1 | 2018 | 143 | 0.160 |
Why?
|
Respiratory Muscles | 1 | 2018 | 140 | 0.160 |
Why?
|
Hemoptysis | 1 | 2019 | 155 | 0.150 |
Why?
|
Asthma | 3 | 2023 | 5955 | 0.150 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 1801 | 0.150 |
Why?
|
Tranexamic Acid | 1 | 2019 | 146 | 0.150 |
Why?
|
Anti-Bacterial Agents | 2 | 2012 | 7153 | 0.140 |
Why?
|
Serotonin Receptor Agonists | 2 | 1997 | 154 | 0.140 |
Why?
|
Women | 1 | 2018 | 230 | 0.140 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2016 | 770 | 0.140 |
Why?
|
Adult | 30 | 2024 | 213712 | 0.140 |
Why?
|
Lymphomatoid Papulosis | 1 | 1995 | 16 | 0.130 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 932 | 0.130 |
Why?
|
Self Care | 1 | 2020 | 786 | 0.130 |
Why?
|
Double-Blind Method | 4 | 2023 | 12017 | 0.130 |
Why?
|
Eating | 1 | 2022 | 1535 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1199 | 0.120 |
Why?
|
Chemokine CXCL10 | 1 | 2015 | 304 | 0.120 |
Why?
|
Salivary Proteins and Peptides | 1 | 2014 | 52 | 0.120 |
Why?
|
Indoles | 2 | 2021 | 1834 | 0.120 |
Why?
|
Emergencies | 1 | 2020 | 1164 | 0.120 |
Why?
|
Exercise Tolerance | 1 | 2018 | 770 | 0.110 |
Why?
|
Saliva | 2 | 2015 | 805 | 0.110 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 687 | 0.110 |
Why?
|
Nose | 1 | 2016 | 509 | 0.110 |
Why?
|
Polymerase Chain Reaction | 2 | 1999 | 6171 | 0.110 |
Why?
|
Epidermal Growth Factor | 1 | 2015 | 709 | 0.110 |
Why?
|
Interleukin-8 | 1 | 2015 | 689 | 0.110 |
Why?
|
Body Composition | 1 | 2022 | 2400 | 0.110 |
Why?
|
Young Adult | 14 | 2023 | 56350 | 0.100 |
Why?
|
Fontan Procedure | 1 | 2018 | 768 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2015 | 638 | 0.100 |
Why?
|
Pyrazoles | 2 | 2021 | 1970 | 0.100 |
Why?
|
Lymphoproliferative Disorders | 1 | 1995 | 525 | 0.100 |
Why?
|
Humans | 40 | 2024 | 742088 | 0.100 |
Why?
|
Hospitals, Pediatric | 1 | 2020 | 1760 | 0.100 |
Why?
|
Absorptiometry, Photon | 4 | 2022 | 1726 | 0.100 |
Why?
|
Respiratory Function Tests | 3 | 2021 | 1613 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2019 | 1398 | 0.090 |
Why?
|
Bone and Bones | 1 | 2021 | 2575 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2022 | 3278 | 0.090 |
Why?
|
Administration, Inhalation | 1 | 2012 | 1104 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2012 | 600 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3336 | 0.080 |
Why?
|
Herbaspirillum | 1 | 2008 | 4 | 0.080 |
Why?
|
Aminoglycosides | 1 | 2009 | 161 | 0.080 |
Why?
|
Adolescent | 15 | 2022 | 85649 | 0.080 |
Why?
|
Parents | 2 | 2021 | 3387 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3038 | 0.080 |
Why?
|
Drug Synergism | 1 | 2012 | 1791 | 0.080 |
Why?
|
Blood Glucose | 4 | 2024 | 6249 | 0.080 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 1999 | 43 | 0.080 |
Why?
|
Child | 11 | 2021 | 77478 | 0.080 |
Why?
|
Intestines | 1 | 2016 | 1923 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2014 | 828 | 0.070 |
Why?
|
Skin Diseases | 1 | 1995 | 1065 | 0.070 |
Why?
|
Treatment Failure | 1 | 2012 | 2615 | 0.070 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2008 | 232 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 2997 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2018 | 3801 | 0.070 |
Why?
|
Female | 25 | 2023 | 379592 | 0.070 |
Why?
|
Sweat | 2 | 2018 | 49 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5611 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5724 | 0.060 |
Why?
|
Desensitization, Immunologic | 1 | 2009 | 483 | 0.060 |
Why?
|
Mutation | 4 | 2023 | 29717 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5238 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3502 | 0.060 |
Why?
|
Male | 23 | 2023 | 349538 | 0.060 |
Why?
|
Bionics | 1 | 2024 | 42 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2853 | 0.060 |
Why?
|
Bronchi | 1 | 2008 | 840 | 0.060 |
Why?
|
Employment | 1 | 2010 | 1124 | 0.060 |
Why?
|
Pseudomonas Infections | 1 | 2008 | 608 | 0.060 |
Why?
|
Insulin Infusion Systems | 1 | 2024 | 212 | 0.050 |
Why?
|
Audiometry | 2 | 2016 | 242 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6483 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 1945 | 0.050 |
Why?
|
Pregnancy, Unplanned | 1 | 2023 | 95 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4566 | 0.050 |
Why?
|
Drug Hypersensitivity | 1 | 2009 | 883 | 0.050 |
Why?
|
Genes, T-Cell Receptor gamma | 1 | 1999 | 15 | 0.050 |
Why?
|
Receptor, Serotonin, 5-HT2A | 2 | 1997 | 74 | 0.040 |
Why?
|
Cough | 1 | 2023 | 555 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 1999 | 193 | 0.040 |
Why?
|
Inspiratory Capacity | 1 | 2018 | 36 | 0.040 |
Why?
|
3T3 Cells | 2 | 1997 | 1101 | 0.040 |
Why?
|
Phenylalanine | 2 | 1997 | 365 | 0.040 |
Why?
|
Lymphoid Tissue | 1 | 1999 | 455 | 0.040 |
Why?
|
Jurkat Cells | 1 | 1999 | 742 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11695 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 24913 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2022 | 21719 | 0.040 |
Why?
|
Diet Surveys | 1 | 2022 | 1172 | 0.040 |
Why?
|
Bufotenin | 1 | 1997 | 1 | 0.040 |
Why?
|
Methoxydimethyltryptamines | 1 | 1997 | 2 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1684 | 0.040 |
Why?
|
Radioligand Assay | 1 | 1997 | 379 | 0.040 |
Why?
|
Antifibrinolytic Agents | 1 | 2019 | 254 | 0.040 |
Why?
|
Hyperplasia | 1 | 1999 | 1183 | 0.030 |
Why?
|
Lung | 3 | 2023 | 9826 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1792 | 0.030 |
Why?
|
Phosphatidylinositols | 1 | 1997 | 291 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3678 | 0.030 |
Why?
|
Keratinocytes | 1 | 1999 | 797 | 0.030 |
Why?
|
Infant | 4 | 2024 | 35070 | 0.030 |
Why?
|
Parenting | 1 | 2021 | 676 | 0.030 |
Why?
|
Ergolines | 1 | 1995 | 60 | 0.030 |
Why?
|
DNA Primers | 1 | 1999 | 2892 | 0.030 |
Why?
|
Critical Pathways | 1 | 2019 | 475 | 0.030 |
Why?
|
Contraception | 1 | 2018 | 356 | 0.030 |
Why?
|
Models, Chemical | 1 | 1997 | 626 | 0.030 |
Why?
|
Point Mutation | 2 | 1997 | 1624 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2015 | 411 | 0.030 |
Why?
|
Fertility | 1 | 2018 | 770 | 0.030 |
Why?
|
Middle Aged | 9 | 2021 | 213127 | 0.030 |
Why?
|
Drug Combinations | 1 | 2018 | 1961 | 0.030 |
Why?
|
United States | 4 | 2023 | 69693 | 0.030 |
Why?
|
Child, Preschool | 4 | 2018 | 40955 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 956 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 40054 | 0.030 |
Why?
|
Spirometry | 1 | 2015 | 862 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 53187 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1869 | 0.030 |
Why?
|
Immunoassay | 1 | 2015 | 752 | 0.030 |
Why?
|
Program Evaluation | 1 | 2020 | 2485 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2021 | 2556 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2019 | 13921 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 2866 | 0.020 |
Why?
|
Vocational Guidance | 1 | 2010 | 13 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2008 | 18112 | 0.020 |
Why?
|
Binding Sites | 2 | 1997 | 6115 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29087 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 2680 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2818 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6575 | 0.020 |
Why?
|
Kinetics | 1 | 1997 | 6474 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 2074 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2018 | 2050 | 0.020 |
Why?
|
Transfection | 1 | 1997 | 5892 | 0.020 |
Why?
|
Genes, rRNA | 1 | 2008 | 70 | 0.020 |
Why?
|
Burkholderia cepacia complex | 1 | 2008 | 25 | 0.020 |
Why?
|
Down-Regulation | 1 | 1995 | 3001 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2924 | 0.020 |
Why?
|
Nasal Mucosa | 1 | 2010 | 373 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 77098 | 0.020 |
Why?
|
Haemophilus influenzae | 1 | 2008 | 171 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2010 | 1135 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6931 | 0.020 |
Why?
|
DNA, Ribosomal | 1 | 2008 | 289 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2008 | 1086 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6608 | 0.020 |
Why?
|
Base Sequence | 2 | 1995 | 12797 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6452 | 0.020 |
Why?
|
Aged | 4 | 2023 | 162944 | 0.020 |
Why?
|
Bacterial Adhesion | 1 | 2008 | 316 | 0.020 |
Why?
|
RNA, Bacterial | 1 | 2008 | 391 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 1003 | 0.020 |
Why?
|
Ion Channels | 1 | 2010 | 1056 | 0.020 |
Why?
|
DNA | 1 | 1999 | 7289 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40450 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 62966 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8297 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2030 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2008 | 947 | 0.020 |
Why?
|
Decision Making | 1 | 2018 | 3869 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 1999 | 14720 | 0.020 |
Why?
|
Virulence Factors | 1 | 2008 | 509 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12695 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12946 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15530 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2008 | 1465 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1995 | 13814 | 0.010 |
Why?
|
Rats | 2 | 1997 | 24265 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 25575 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19223 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20086 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2009 | 1389 | 0.010 |
Why?
|
Phylogeny | 1 | 2008 | 2797 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 1994 | 3058 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 1 | 2008 | 1210 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 1449 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2008 | 1477 | 0.010 |
Why?
|
Mice | 3 | 2008 | 81045 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18355 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4801 | 0.010 |
Why?
|
Animals | 5 | 2008 | 168561 | 0.010 |
Why?
|
Ergotamine | 1 | 1995 | 7 | 0.010 |
Why?
|
Ketanserin | 1 | 1995 | 26 | 0.010 |
Why?
|
Amphetamines | 1 | 1995 | 148 | 0.010 |
Why?
|
Logistic Models | 1 | 2009 | 13403 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23320 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 1723 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 20928 | 0.010 |
Why?
|
Isoenzymes | 1 | 1995 | 1725 | 0.010 |
Why?
|
Protein Kinase C | 1 | 1995 | 1227 | 0.010 |
Why?
|
Molecular Structure | 1 | 1994 | 1907 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1995 | 3133 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72145 | 0.010 |
Why?
|
Ligands | 1 | 1995 | 3293 | 0.010 |
Why?
|
Models, Molecular | 1 | 1995 | 5454 | 0.000 |
Why?
|
Protein Binding | 1 | 1995 | 9387 | 0.000 |
Why?
|
Cell Line | 1 | 1994 | 15994 | 0.000 |
Why?
|
Concepts
(232)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_